Hrt Financial LP Concert Pharmaceuticals, Inc. Transaction History

Hrt Financial LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.8 - $6.36 $40,516 - $92,029	-14,470 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.73 - $3.94 $39,503 - $57,011	14,470 New	14,470 $48,000
Q4 2021 Feb 14, 2022	SELL	$2.69 - $4.22 $183,939 - $288,559	-68,379 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$3.17 - $4.15 $56,121 - $73,471	-17,704 Reduced 20.57%	68,379 $223,000
Q2 2021 Aug 16, 2021	BUY	$3.77 - $5.24 $324,532 - $451,074	86,083 New	86,083 $363,000
Q1 2020 May 15, 2020	SELL	$5.98 - $13.09 $99,429 - $217,647	-16,627 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$5.71 - $9.22 $94,940 - $153,300	16,627 New	16,627 $153,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.